Stay updated on Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:17:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3; no changes to study content or page functionality are indicated.
    Difference
    0.1%
    Check dated 2026-03-11T23:57:06.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2026-02-11T11:30:08.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operations status, with guidance to check opm.gov for updates. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:21.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Show glossary feature added and QC metadata labels updated, including a revision/version tag. Core trial data and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:48:58.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; no user-facing content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:43.000Z thumbnail image

Stay in the know with updates to Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.